There was a significant (p ≤ 0.05) decrease (38%) in full-length mutant APP levels in brain homogenates of AD-Tg mice treated with NMN as compared to AD-Tg vehicle-treated mice (Figure 2). Here, APP is linked to Alzheimer disease.